Contact Us Support Us Sitemap
   
 

Abstract Submission Details

On 4th April the deadline for abstract submission passed. We now have new agreements for the abstracts. From the 4th April onwards:

1. Please note the Special Headings very deliberately chosen for the type of meeting it is.

2. Abstracts submitted after 4th April will not be bound in the program. However, they will be mounted on the website and circulated to the Discussion Leaders for consideration.

3. Those wishing to speak to their abstracts should indicate this as the final program will be put in stone on 15th April however some flexibility will be allowed in the program for late chosen speakers.

4. Those unable to attend but who have valuable ideas/pilots/plans are encouraged to send abstracts in for circulation and inclusion in discussion. Authors of such abstracts may be included in the authorship of the multi-author Nature Genetics paper.

5. You do not have to submit an abstract with ideas/pilots/plans to attend. You can also submit an abstract to be considered, but choose not to speak to it.

There will be no posters at this meeting due to the nature of the meeting.

 

Abstracts must be related to one of the following discussion topics:

  • Ethics
  • Data collection from laboratories
  • Data collection from clinics
  • Data transfer & databasing (gene specific ) (LSDB)
  • Overall data integration & access
  • Assessment of pathogenicity
  • Publication, credit & incentives
  • Developing/Emerging countries & world wide collection
  • Funding mechanisms & governance
  • Pilot projects already covering several components

Instructions for preparing abstracts

This meeting is purely (a) to inform those interested worldwide as to what relevant projects are already being performed, (b) to develop plans for worldwide collaborative projects to spread the load and avoid wasteful duplication, (c) provide material for a high profile multi-author publication and for grant applications.

Thus, the problem of the collection of variation and their effects are well known after being discussed in Melbourne June 2006 and the 96 recommendations to overcome them published in a high profile journal “Nature Genetics”. Consequently the content of abstracts and presentations should take the problems for granted and discuss any current work or system and plans for the future and potential collaboration with others with similar systems or potential partners.

Abstracts will be scrutinized for conformity to the above and sent for revision if necessary. Those with key data, plans or systems unable to attend due to competing events may, or will be invited to send abstracts for inclusion in plans and publications.

Because of the nature of the meeting 1 page abstracts, which will be placed online (unless the author(s) object) should have the following headings and content:

  • Title, Authors and Affiliation including email addresses.

  • Problems being Addressed: 1-2 sentences.

  • Systems or Plans being described: the bulk of the abstract should address this with references to published or other relevant work or Websites.

  • Collaborations or Sharing Capacity: this should be several sentences including the ability for transfer to other genes and/or countries.

  • Topic section preferred.

In the event we receive more abstracts than speaking places, the most relevant will be chosen for presentation but the others will be printed in the program and placed online. Importantly the content will be taken into account by the discussion leaders in future planning and subsequent publications. The presentations should emphasize current systems and plans available and then those of the speaker.

Instructions for abstract Style

2.5 cm margins

Font type = Arial

Headings should be bold and 14 point and CAPITAL letters

Text Font size = 11 point

Authors 11 point font. Put surname first followed by initials. Please underline the presenting author.

Please give full addresses of all authors (without titles) after the heading. Please indicate the name of the corresponding author by an asterisk*.

The Email of the corresponding author should be included below the addresses.

URLs of all databases referenced should be included.

Diagrams and tables may be included but this is part of your 1 page limit.

Nomenclature for mutations must follow HGVS guidelines.

Nomenclature for genes must follow HGNC guidelines.

Submission

Please save your abstract using THE PRESENTERS surname and first name initial.

e.g. John Smith's abstract would be "smithJ.doc "

e-mail your submission as an Word attachment to rania@gdrc.hfi.unimelb.edu.au

A submission may be made electronically only.

Please include a small cover note in the email indicating which meeting the abstract is for (e.g., "I wish to submit this abstract for the HVP Planning meeting"), cryptic messages or abstracts emailed with no note attached are unacceptable as they look like virus attachments and will not be opened.

If you have any problems let us know.

Please ensure you receive an acknowledgement after you have sent your abstract so you are sure it has been received, allow a couple of days. Regarding selection for presentation, if you do not hear back by mid April 2008 please make an enquiry as you may not have received the email notification.

ORAL PRESENTATIONS

IMPORTANT INSTRUCTIONS FOR ORAL PRESENTATIONS

1. All presentations will be allocated a time limit including question time. Anyone going overtime will be CUT SHORT so please keep to the time limit.

2. Only PowerPoint presentations are available, there will be NO slide or overhead projector available.

3. Acceptable formats for presentations are CD or USB memory stick. Speakers ARE NOT to expect to use their own laptop as this wastes a lot of time.

4. You MUST either submit your presentation via EMAIL by 21st May 2008 (& bring a copy) OR DELIVER your presentation at the registration desk on the 25th May. If you choose to give it in person, a CD labeled with your surname is probably best because you can just leave it on the desk and it will get loaded onto the computer.